drugset
drugset / Trial / NCT06837116

Immunogenicity of an Intradermal Qdenga Vaccine Among Healthy Volunteers

NCT06837116 ↗

Phase 0 Completed 29 enrolled Prince of Songkla University
RandomizedParallel-groupOpen-labelBasic science

Summary

Official title: Immunogenicity of an intradermal Qdenga vaccine among healthy volunteers: A pilot study

Timeline

Start
2025-04-19
Primary completion
2025-08-30
Completion
2025-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject DENGUE VIRUS, LIVE ATTENUATED Vaccine — Subcutaneous

Indications

dengue disease